GLMD logo

Galmed Pharmaceuticals (GLMD) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$2.86 M
+$845.00 K+41.91%

December 31, 2023


Summary


Performance

GLMD Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLMDbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$9.72 M
+$7.89 M+429.34%

September 30, 2024


Summary


Performance

GLMD Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLMDbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

GLMD Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+41.9%+556.1%
3 y3 years-58.8%+556.1%
5 y5 years-88.2%+556.1%

GLMD Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.8%+41.9%at high+863.7%
5 y5-year-82.0%+41.9%-41.6%+863.7%
alltimeall time-88.2%+1988.3%-75.5%+6997.8%

Galmed Pharmaceuticals Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$9.72 M(+429.3%)
Jun 2024
-
$1.84 M(+25.6%)
Mar 2024
-
$1.46 M(-48.9%)
Dec 2023
$2.86 M(+41.9%)
$2.86 M(+93.0%)
Sep 2023
-
$1.48 M(+46.9%)
Jun 2023
-
$1.01 M(-39.7%)
Mar 2023
-
$1.67 M(-17.1%)
Dec 2022
$2.02 M(-30.1%)
$2.02 M(-50.4%)
Sep 2022
-
$4.06 M(+105.1%)
Jun 2022
-
$1.98 M(-47.1%)
Mar 2022
-
$3.74 M(+29.7%)
Dec 2021
$2.88 M(-58.5%)
$2.88 M(-17.4%)
Sep 2021
-
$3.49 M(-56.0%)
Jun 2021
-
$7.92 M(-40.8%)
Mar 2021
-
$13.38 M(+92.7%)
Dec 2020
$6.95 M(-56.4%)
$6.95 M(-58.3%)
Sep 2020
-
$16.65 M(+199.8%)
Jun 2020
-
$5.55 M(-58.3%)
Mar 2020
-
$13.32 M(-16.4%)
Dec 2019
$15.93 M
$15.93 M(-12.9%)
Sep 2019
-
$18.29 M(-29.0%)
Jun 2019
-
$25.78 M(-31.0%)
DateAnnualQuarterly
Mar 2019
-
$37.34 M(+54.6%)
Dec 2018
$24.16 M(+85.5%)
$24.16 M(-7.0%)
Sep 2018
-
$25.98 M(+322.4%)
Jun 2018
-
$6.15 M(+133.8%)
Mar 2018
-
$2.63 M(-79.8%)
Dec 2017
$13.02 M(+320.4%)
$13.02 M(+398.1%)
Sep 2017
-
$2.61 M(+49.6%)
Jun 2017
-
$1.75 M(+5.2%)
Mar 2017
-
$1.66 M(-46.4%)
Dec 2016
$3.10 M(-25.5%)
$3.10 M(-56.0%)
Sep 2016
-
$7.04 M(+138.8%)
Jun 2016
-
$2.95 M(-4.5%)
Mar 2016
-
$3.08 M(-25.8%)
Dec 2015
$4.16 M(-82.5%)
$4.16 M(-6.9%)
Sep 2015
-
$4.46 M(-39.1%)
Jun 2015
-
$7.32 M(+213.0%)
Mar 2015
-
$2.34 M(-90.1%)
Dec 2014
$23.74 M(>+9900.0%)
$23.74 M(-32.8%)
Sep 2014
-
$35.34 M(-5.5%)
Jun 2014
-
$37.40 M(-6.0%)
Mar 2014
-
$39.77 M(>+9900.0%)
Dec 2013
$137.00 K(-80.9%)
$137.00 K
Dec 2012
$718.00 K
-

FAQ

  • What is Galmed Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Galmed Pharmaceuticals quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

What is Galmed Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of GLMD is $2.86 M

What is the all time high annual cash & cash equivalents for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high annual cash & cash equivalents is $24.16 M

What is Galmed Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, GLMD annual cash & cash equivalents has changed by +$845.00 K (+41.91%)

What is Galmed Pharmaceuticals quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of GLMD is $9.72 M

What is the all time high quarterly cash and cash equivalents for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high quarterly cash and cash equivalents is $39.77 M

What is Galmed Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

Over the past year, GLMD quarterly cash and cash equivalents has changed by +$8.24 M (+556.14%)